CORE LABORATORIES INC.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $22.7M | $22.8M | $22.7M | $25.6M | $31.2M | $22.1M | $19.2M | $21.5M |
| Accounts Receivable | $108.8M | $108.3M | $113.5M | $110.3M | $113.9M | $117.0M | $111.8M | $117.6M |
| Inventory | $58.0M | $57.8M | $54.5M | $58.2M | $59.8M | $59.0M | $59.4M | $65.5M |
| Total Current Assets | $214.4M | $214.4M | $214.7M | $226.9M | $237.7M | $228.8M | $221.3M | $235.2M |
| Property, Plant & Equipment | $100.4M | $100.0M | $99.4M | $98.0M | $97.9M | $97.9M | $97.1M | $97.6M |
| Goodwill | $105.8M | $105.8M | $105.8M | $100.0M | $100.0M | $99.4M | $99.4M | $99.4M |
| Intangible Assets (Excl. Goodwill) | $6.8M | $6.9M | $7.1M | $6.1M | $6.2M | $6.3M | $6.4M | $6.5M |
| Total Assets | $586.8M | $587.7M | $584.0M | $591.4M | $596.8M | $586.2M | $585.1M | $600.5M |
| Liabilities | ||||||||
| Accounts Payable | $40.2M | $40.0M | $37.3M | $36.9M | $41.7M | $38.5M | $34.5M | $33.6M |
| Total Current Liabilities | $101.1M | $104.7M | $106.0M | $95.7M | $104.8M | $103.7M | $102.4M | $94.9M |
| Long-Term Debt | $113.9M | $114.5M | $110.3M | $114.1M | $124.6M | $124.4M | $126.1M | $139.9M |
| Total Liabilities | $314.1M | $318.8M | $318.0M | $320.0M | $335.6M | $332.9M | $338.6M | $349.7M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $176.9M | $171.4M | $172.7M | $173.6M | $159.8M | $149.7M | $144.9M | $143.3M |
| Total Stockholders' Equity | $272.7M | $268.9M | $266.0M | $271.3M | $261.3M | $253.4M | $246.6M | $250.7M |